Paper Details 
Original Abstract of the Article :
OBJECTIVE: To explore the usefulness of number needed to treat to be harmed (NNTH), in benefit-risk assessments, by studying the agreement between NNTH values and withdrawals of medicines from European market due to safety reasons. METHODS: Medicines with data from longitudinal studies were include...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1080/14740338.2016.1217989

データ提供:米国国立医学図書館(NLM)

The Importance of Number Needed to Treat to Be Harmed (NNTH) in Drug Safety Evaluations

In the vast desert of drug development, we're always striving to find the perfect oasis of safety and efficacy. But sometimes, even after careful evaluation, a drug might turn out to be more of a mirage than a life-saving solution. This research delves into the crucial role of the number needed to treat to be harmed (NNTH) in benefit-risk assessments, particularly when it comes to medicines withdrawn from the European market due to safety concerns.

The study employed a meta-analysis approach, pooling odds ratios (OR) from longitudinal studies to calculate NNTH values for various adverse events. The results revealed a striking trend: NNTH values tended to decrease from pre-marketing to post-marketing phases for most of the medicines analyzed. For example, the NNTH for developing peripheral neuropathy with almitrine increased from infinity (pre-marketing) to 12 (post-marketing), highlighting the critical importance of continued surveillance even after drug approval.

NNTH: A Guiding Light in the Desert of Drug Safety

This study underlines the immense value of NNTH in making informed decisions about drug safety. By providing a clear and concise measure of the risk of harm associated with a drug, NNTH can serve as a valuable compass for regulators and healthcare professionals alike.

Navigating the Sands of Drug Safety

The findings suggest that NNTH has the potential to be a powerful tool in benefit-risk re-evaluations of medicines, assisting regulators in making informed decisions about drug safety. While the desert of drug development can be vast and unforgiving, NNTH can provide a valuable oasis of insight, helping us to navigate the complex landscape of drug safety and optimize patient well-being.

Dr.Camel's Conclusion

This study sheds light on the importance of monitoring drug safety even after a medicine has been approved. The NNTH, much like a trusty camel in the desert, helps us assess the potential risks of a drug, allowing us to make informed decisions to protect patient health and minimize harm.

Date :
  1. Date Completed 2017-02-27
  2. Date Revised 2017-02-27
Further Info :

Pubmed ID

27467204

DOI: Digital Object Identifier

10.1080/14740338.2016.1217989

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.